Total Search Results for "{{searchedParams.q}}" : {{searchedData.data.hits.total}}
{{item.content_type}}
No search results for this term, please try again.

Feng-Hua (Ellen) Loh, BSPharm, MBA, PhD

Instructor

Ellen Loh 2
  • Office: 2090 Adam Clayton Powell Jr. Blvd, 603E, New York, NY 10027
  • Phone:
    929-333-8345
  • Email:
    fenghua.loh@touro.edu

Education

University of Maryland Baltimore, PhD, MD: 2016

University of the Sciences in Philadelphia, MBA,  PA; 2006

National Taiwan University, BS, Taiwan; 2004 

Clinical Specialty

Geriatrics

Research

Medication use, adherence, and outcomes in the Medicare population with chronic diseases

Medicare Part D policy such as MTM and benefit design

Academic and Professional Honors

  • 2014 Student Poster Fellowship, Drug Information Association (DIA) 50th Annual Meeting
  • 2014 Travel Fellowship, Graduate Student Association, University of Maryland Baltimore
  • 2014 Travel Award, Department of Pharmaceutical Health Services Research, University of Maryland Baltimore
  • 2009-present The Rho Chi Society 

Teaching responsibilities

PHRM 570: Drug Information, Pharmacoepidemiology, and Biostatistics

PHRM 530: Principles of Management, Pharmacoeconomics and Outcomes Research

PHRM 510: Foundations of Public Health III-Biostatistics and Epidemiology

SBAN 571: Professional Practice II-Patient-Provider Communication

SBAN 688: Pharmacoepidemiology

Publications

Peer Reviewed Publications

Chou J., Brandt N., Loh F.E., Stuart B. “Differences among Antipsychotic Users Enrolled in Stand-Alone Prescription Drug Plans and Medicare Advantage Plans in 2008.” The Consultant Pharmacist. In press.
 
Stuart B., Shen X., Quinn C., Brandt N., Roberto P., Loh F.E., Hendrick F., Kim C., Huang X., Rajpathak S. “Proximal Predictors of Discontinuance with Oral Antidiabetic Agents among the Elderly.” Journal of Managed Care Pharmacy. Journal of Managed Care Pharmacy. 2016;22(9):1019-27.  
 

Tan E., Yang G., Pang B., Dai M., Loh F.E., Hogan P. “Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control among Patients with Type 2 Diabetes.” Journal of Managed Care Pharmacy 2015;21(12):1195-202. 

Stuart B., Dai M., Xu J., Loh F.E., Shoemaker J.S. “Does Good Medication Adherence Really Save Payers Money?” Medical Care. 2015;53(6):517-23.

Loh F.E., Stuart B., Zuckerman I.H. “Treatment Patterns for Osteoporosis in Elderly Women Residing in the Community and Long-Term Care Facilities Enrolled in Medicare.” Journal of Pharmaceutical Health Services Research. 2015;6(1):19-26.

Stuart B., Loh F.E., Roberto P.N., Miller L. “Incident User Cohorts to Assessing Medication Cost-Offsets.” Health Services Research. 2014;49(4):1364-86.

Stuart B., Loh F.E., Magder L., Shaffer T., Park J., Zacker C. “Anticipating Changes in Drug Coverage: How Elderly Heart Failure Patients Respond to Medicare Part D Benefit Phases.” Journal of Pharmaceutical Care and Health Systems. 2014;1(1):104.

Stuart B., Loh F.E., Miller L., Roberto P.N. “Should Eligibility for Medication Therapy Management Be Based on Drug Adherence?” Journal of Managed Care Pharmacy. 2014;20(1):66-75.

Stuart B., Loh F.E., Roberto P.N., Miller L. “Increasing Medicare Part D Enrollment in Medication Therapy Management Could Improve Health and Lower Costs.” Health Affairs. 2013;32(7):1212-20.

Onukwugha E., Saunders E., Mullins C.D. Pradel F.G., Zuckerman M., Loh F.E., Weir M.R. “A Qualitative Study to Identify Reasons for Discharges against Medical Advice in the Cardiovascular Setting.” BMJ Open. 2012;2(4):e000902.

Stuart B., Loh F.E. “Medicare Part D Enrollees’ Use of Out-of-Plan Discounted Generic Drugs.” Journal of the American Geriatrics Society. 2012;60(2):387-8.

Onukwugha E., Mullins C.D., Loh F.E., Saunders E., Shaya F.T., Weir M.R. “Readmissions after Unauthorized Discharges in the Cardiovascular Setting.” Medical Care. 2011;49(2):215-24.

Wertheimer A.I., Loh E.F. “Making Pharmaceuticals Affordable in Lesser Developed Countries: A Public Health Role for the Pharmacist.” Journal of Public Health Pharmacy. 2008;1(1):3-15.

Non Peer Reviewed Publications

Books

1. Stuart B., Loh F.E., Xu J., Roberto P.N., Shoemaker J.S. “Medication Utilization Patterns and Outcomes among Part D Enrollees with Common Chronic Diseases.” PhRMA, Washington, DC, 2014. http://www.pharmacy.umaryland.edu/centers/lamy/pdf/Part_D_Chartbook_Final_2014.pdf

Book Chapter

1. Loh F.E. “The Financial and Economic Aspects of Counterfeit Medicines.” In Counterfeit Medicines Volume 1: Policy, Economics and Countermeasures. Ed. Albert I. Wertheimer and Perry G. Wang. ILM Publications, Hertfordshire, UK, 2012.

Book Review

1Loh F. Book Review of “Drugs for Less: The Complete Guide to Free and Discounted Prescription Drugs, Featuring More Than 600 of The Most Commonly Prescribed Medications”, by Michael P. Cecil, MD. New York: Hatherleigh Press, 2005. Journal of Pharmaceutical Finance, Economics and Policy. 2007;15(2):121-23.

Letter to Editor

1. Stuart B., Loh F.E. “Response Letter to Jonathan Harding.” Journal of the American Geriatrics Society. 2013;61(2):310.

Journal Articles

1. Wertheimer A.I., Loh E.F. “Getting Value from End-of-Life-Cycle Pharmaceuticals.” Pharmaceutical Commerce. 2009;4(9).

2. Wertheimer A.I., Loh E.F., Poli L.G. “Lifecycle: End Game.” Pharmaceutical Executive. 2007;27(10).

3. Wertheimer A.I., Loh F. “Getting Better?” Pharmaceutical Executive. 2006;26(8):72-84. 

Interests/Hobbies/Life Outside of Work

Baking, Cooking, Hiking, Traveling, Classic and Jazz Music, Jigsaw Puzzles